169 related articles for article (PubMed ID: 30768365)
1. iPSC- and mesenchymoangioblast-derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid.
Royce SG; Mao W; Lim R; Kelly K; Samuel CS
FASEB J; 2019 May; 33(5):6402-6411. PubMed ID: 30768365
[TBL] [Abstract][Full Text] [Related]
2. Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease.
Royce SG; Rele S; Broughton BRS; Kelly K; Samuel CS
FASEB J; 2017 Sep; 31(9):4168-4178. PubMed ID: 28626025
[TBL] [Abstract][Full Text] [Related]
3. Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease.
Royce SG; Tominaga AM; Shen M; Patel KP; Huuskes BM; Lim R; Ricardo SD; Samuel CS
Clin Sci (Lond); 2016 Dec; 130(23):2151-2165. PubMed ID: 27647937
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease.
Royce SG; Shen M; Patel KP; Huuskes BM; Ricardo SD; Samuel CS
Stem Cell Res; 2015 Nov; 15(3):495-505. PubMed ID: 26426509
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma.
Royce SG; Patel KP; Samuel CS
Lab Invest; 2014 Dec; 94(12):1326-39. PubMed ID: 25264707
[TBL] [Abstract][Full Text] [Related]
6. Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.
Royce SG; Lim CX; Patel KP; Wang B; Samuel CS; Tang ML
Clin Exp Allergy; 2014 Nov; 44(11):1399-408. PubMed ID: 25113628
[TBL] [Abstract][Full Text] [Related]
7. Human pluripotent stem cell-derived mesenchymal stem cells prevent chronic allergic airway inflammation via TGF-β1-Smad2/Smad3 signaling pathway in mice.
Zhong H; Fan XL; Fang SB; Lin YD; Wen W; Fu QL
Mol Immunol; 2019 May; 109():51-57. PubMed ID: 30852246
[TBL] [Abstract][Full Text] [Related]
8. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
[TBL] [Abstract][Full Text] [Related]
9. Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.
Patel KP; Giraud AS; Samuel CS; Royce SG
Br J Pharmacol; 2016 Jun; 173(12):2016-29. PubMed ID: 27060978
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of compact bone-derived mesenchymal stem cells on chronic airway remodeling in murine model of asthma.
Ogulur I; Gurhan G; Aksoy A; Duruksu G; Inci C; Filinte D; Kombak FE; Karaoz E; Akkoc T
Int Immunopharmacol; 2014 May; 20(1):101-9. PubMed ID: 24613203
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effects of Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on a Murine Model of Acute Type-2-Dominated Airway Inflammation.
Ma SY; Zhao N; Cui L; Li Y; Zhang H; Wang J; Pang J; Wang M; Wang C; Ying S; Jin ZB; Zhang L
Stem Cell Rev Rep; 2022 Dec; 18(8):2939-2951. PubMed ID: 35622293
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease.
Chakraborty A; Pinar AA; Lam M; Bourke JE; Royce SG; Selomulya C; Samuel CS
Biomaterials; 2021 Jun; 273():120796. PubMed ID: 33894403
[TBL] [Abstract][Full Text] [Related]
13. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice.
Sun YQ; Deng MX; He J; Zeng QX; Wen W; Wong DS; Tse HF; Xu G; Lian Q; Shi J; Fu QL
Stem Cells; 2012 Dec; 30(12):2692-9. PubMed ID: 22987325
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways.
Li X; Michaeloudes C; Zhang Y; Wiegman CH; Adcock IM; Lian Q; Mak JCW; Bhavsar PK; Chung KF
J Allergy Clin Immunol; 2018 May; 141(5):1634-1645.e5. PubMed ID: 28911970
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells without c-Myc reduce airway responsiveness and allergic reaction in sensitized mice.
Wang CY; Chiou GY; Chien Y; Wu CC; Wu TC; Lo WT; Chen SJ; Chiou SH; Peng HJ; Huang CF
Transplantation; 2013 Dec; 96(11):958-65. PubMed ID: 23989473
[TBL] [Abstract][Full Text] [Related]
16. Trefoil factor-2 reverses airway remodeling changes in allergic airways disease.
Royce SG; Lim C; Muljadi RC; Samuel CS; Ververis K; Karagiannis TC; Giraud AS; Tang ML
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):135-44. PubMed ID: 22652198
[TBL] [Abstract][Full Text] [Related]
17. [Effects of human mesenchymal stem cells on airway inflammation in allergic asthma mice and the underlying mechanism].
Ren NN; Chen HJ; Chen QL; Eileen J; An YG; Lin Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2697-2702. PubMed ID: 28910960
[No Abstract] [Full Text] [Related]
18. Evaluation of Human MSCs Treatment Frequency on Airway Inflammation in a Mouse Model of Acute Asthma.
Hur J; Kang JY; Kim YK; Lee SY; Jeon S; Kim Y; Jung CK; Rhee CK
J Korean Med Sci; 2020 Jun; 35(23):e188. PubMed ID: 32537953
[TBL] [Abstract][Full Text] [Related]
19. Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma.
Trzil JE; Masseau I; Webb TL; Chang CH; Dodam JR; Cohn LA; Liu H; Quimby JM; Dow SW; Reinero CR
Clin Exp Allergy; 2014 Dec; 44(12):1546-57. PubMed ID: 25220646
[TBL] [Abstract][Full Text] [Related]
20. The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment.
Wang SY; Fan XL; Yu QN; Deng MX; Sun YQ; Gao WX; Li CL; Shi JB; Fu QL
Stem Cell Res Ther; 2017 Jan; 8(1):2. PubMed ID: 28057064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
